| P50 | author | Kathleen Falster | Q37370838 |
| | Jun Yong Choi | Q40143606 |
| P2093 | author name string | Matthew G Law | |
| | Brian Mulhall | |
| | Jialun Zhou | |
| | Australian HIV Observational Database | |
| | Basil Donovan | |
| | Chris Duncombe | |
| | TREAT Asia HIV Observational Database | |
| | David Sowden | |
| P2860 | cites work | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
| | 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults | Q28184343 |
| | Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 |
| | The global burden of hepatitis C | Q29620138 |
| | The TREAT Asia HIV Observational Database: baseline and retrospective data | Q30981390 |
| | Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil | Q33317290 |
| | Estimation of failure probabilities in the presence of competing risks: new representations of old estimators | Q33594562 |
| | Decline in the AIDS and death rates in the EuroSIDA study: an observational study | Q33967061 |
| | Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study | Q34011661 |
| | Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. | Q34068078 |
| | Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures | Q34302587 |
| | Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis | Q34580943 |
| | Changes in the risk of death after HIV seroconversion compared with mortality in the general population | Q34791057 |
| | HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies | Q34844389 |
| | Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999. | Q35622250 |
| | Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study | Q36247045 |
| | Trends in predictors of death due to HIV-related causes among persons living with AIDS in New York City: 1993-2001. | Q36274689 |
| | Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks | Q36456737 |
| | Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City | Q36597220 |
| | CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection | Q36745251 |
| | Survival following HIV infection of a cohort followed up from seroconversion in the UK. | Q38458940 |
| | Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion | Q40346109 |
| | Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? | Q44055963 |
| | Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3. | Q44203105 |
| | Combination antiretroviral therapy and the risk of myocardial infarction | Q44662157 |
| | Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study | Q45413375 |
| | Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries | Q46391119 |
| | Survival of persons with and without HIV infection in Denmark, 1995-2005. | Q50544706 |
| | Applying Cox Regression to Competing Risks | Q52339900 |
| | Cardio- and cerebrovascular events in HIV-infected persons. | Q53286263 |
| | Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. | Q53608173 |
| | Class of Antiretroviral Drugs and the Risk of Myocardial Infarction | Q57181081 |
| | Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study | Q57877938 |
| | HIV related and non-HIV related mortality before and after the introduction of highly active antiretroviral therapy (HAART) in Norway compared to the general population | Q63430676 |
| | Rates of combination antiretroviral treatment change in Australia, 1997-2000 | Q74283675 |
| | Risk factors and causes of death in the Australian HIV Observational Database | Q79789480 |
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV/AIDS | Q12199 |
| | anti-retroviral agent | Q50430310 |
| P304 | page(s) | 2323-2336 | |
| P577 | publication date | 2009-11-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment | |
| P478 | volume | 23 | |